Blood Glucose in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation

Sponsor
University of Aarhus
Study ID
NCT06794307
Status
Recruiting
Apply to this trial

Conditions

  • Hyperglycemia
  • Neonatal Hypoglycemia
  • Preterm Birth
  • Threatened Preterm Labor

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

In case of threatening preterm birth, it is standard to recommend treatment with betamethasone to accelerate fetal lung maturation. In pregnant women with diabetes, treatment with betamethasone can lead to significant hyperglycemia, which may cause hypoglycemia in the neonate. Changes in blood glucose in non-diabetic women are less investigated. In this study we aim to examine changes in maternal blood glucose levels in non-diabetic women, during treatment with betamethasone, by continuous glucose monitoring. Hypotheses: Administration of betamethasone induce significant hyperglycemia in non-diabetic pregnant women during treatment.

Key Dates

First listed
Jan 27, 2025
Start date
Nov 20, 2024
Status verified
Jan 2025
Primary completion
Oct 30, 2025
Completion
Jan 31, 2026

Study Design

Enrollment
25 participants (estimated)

Primary Outcome Measure

Maternal blood glucose levels before, under and after the administration of betamethasone [ Time Frame: 7-14 days ]

Central Contacts

Related Studies